16 results
PRE 14A
6n2v0rykdil
17 Apr 20
Preliminary proxy
4:18pm
8-K
EX-99.1
cnjzwdj4w8flxl3e
13 Apr 20
ENDRA Life Sciences Announces Cash Strategy and Business Update in Response to COVID-19
4:29pm
8-K
EX-99.1
n2ozmjt5vmk970 c2
10 Mar 20
ENDRA Life Sciences Receives CE Mark for its TAEUS® Clinical Product Targeting Non-Alcoholic Fatty Liver Disease
8:02am
DEF 14A
voopwmnnquq
10 May 18
Definitive proxy
4:08pm
10-K
mctt80k
20 Mar 18
Annual report
12:00am
10-Q
vkiq3sp4
21 Jun 17
Quarterly report
12:00am
- Prev
- 1
- Next